These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3274419)

  • 1. Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipients.
    Vincent HH; Wenting GJ; Jeekel J; Schalekamp MA; Weimar W
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1737-8. PubMed ID: 3274419
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.
    Vanrenterghem Y; Waer M; De Keyser P; Roels L; Michielsen P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):615-7. PubMed ID: 3291296
    [No Abstract]   [Full Text] [Related]  

  • 3. Amelioration of preservation damage but not cyclosporine nephrotoxicity by dihydroergotoxine in kidney transplant recipients. A double-blind placebo-controlled trial.
    Brouwer ML; Wenting GJ; Vincent HH; Hendriks GF; Jeekel J; Weimar W
    Transplantation; 1989 Nov; 48(5):885-6. PubMed ID: 2815264
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine nephrotoxicity and dermal vascular alterations in renal transplants.
    Shen SY; Wood C; Amin AN; Papadimitriou JC; Weir MR; Coughlin TR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1508-10. PubMed ID: 2652486
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 6. An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients.
    Salomon DR
    Transplant Proc; 1991 Aug; 23(4):2115-8. PubMed ID: 1871827
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

  • 8. Posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients.
    Sumrani N; Delaney V; Ding Z; Davis R; Daskalakis P; Friedman EA; Butt KM; Hong JH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1249-50. PubMed ID: 1989201
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term results of cyclosporine therapy in recipients of mismatched living related kidneys.
    Flechner SM; Van Buren CT; Kerman RH; Lorber MI; Barker CJ; Golden DL; Kahan BD
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):44-51. PubMed ID: 3515693
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydergine and reversibility of cyclosporin nephrotoxicity.
    Kho TL; Kengen R; Leunissen KM; Teule J; van Hooff JP
    Lancet; 1986 Aug; 2(8503):394-5. PubMed ID: 2874389
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion from cyclosporine to azathioprine in renal graft recipients.
    MacDonald AS; Belitsky P; Gupta R; Bitter-Suermann H; Campbell R; Cohen A; Lannon SG
    Transplant Proc; 1985 Aug; 17(4):1940-2. PubMed ID: 3895634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
    Smith AY; Van Buren CT; Lewis RM; Kerman RH; Welsh M; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):180-93. PubMed ID: 3291239
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of immunosuppressive problems in renal allograft recipients.
    Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 19. Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients.
    Magalini SC; Nanni G; Sambo A; Agnes S; Luciani G; Pozzetto A; Avolio A; Cittadini A; Castagneto M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1686-8. PubMed ID: 3274405
    [No Abstract]   [Full Text] [Related]  

  • 20. Dallas experience with cyclosporine A (CsA) one to six months posttransplant.
    Hull AR; Atkins CR; Brinker KR; Dawidson I; Dickerman RM; Emerson W; Helderman JH; Levitz B; Long DL; Nesser D
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):128-31. PubMed ID: 3515679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.